Company Overview and News
TECHNOLOGY providers, project developers and investors from Asia, Europe and the US are looking to partner with electric cooperatives in bringing electricity to rural communities by building self-sustaining minigrids.
Mumbai/New Delhi: Lenders to India’s power industry are scheduled to meet on Thursday to discuss ways to resolve ₹1.4 trillion ($19.2 billion) of stressed assets that’s hobbling the sector, people with knowledge of the matter said.
PFC PWQFY 532627 JPPOWER 532955 RECLTD 532810 SBAZ
A sea of red took over D-Street on Monday as selloff in majority of sectors ensured that complete control was handed over to the bears. The Nifty managed to give up 11,400, while the Sensex tanked over 500 points lower.
BAJAJHIND DB 532707 532955 BAJFINANCE DYNPRO BJJQY 500570 RECLTD 500032 TATAMOTORS 500034 TTM
Share price of Rural Electrification Corporation (REC) rose 2.7 percent intraday Monday after foreign research house Deutsche Bank has maintained buy rating on stock with a target of Rs 155 per share.
DB 532955 RECLTD
Mumbai: Indian companies lured by Japan’s near-record low interest rates and easier availability of funds are raising the most yen-denominated loans in more than a decade as dollar lenders turn cautious. While Samurai loans still make up only a small portion of Indian firms’ total foreign-currency facilities, coming to more than 6% this year, they are growing in importance for borrowers. Power Grid Corp.
8306 MUFG 532955 RECLTD MBFJF MTU
The Reserve Bank has turned down the Power Ministry's request to give certain concessions for setting up of an Asset Reconstruction Company (ARC) for warehousing stressed assets to prevent distress sale of these plants, a senior official said Thursday.
Union Minister R K Singh asked lenders of stressed power assets, including state-run Rural Electrification Corporation (REC), to ensure sustainability of electricity projects while addressing the bad loan issue in the sector.
The Allahabad high court’s decision to deny relief to power companies facing debt servicing problems may have stoked fears of a fresh bout of write-offs for the banking sector. But the decision has triggered a rally in the shares of Power Finance Corp. Ltd (PFC), Rural Electrification Corp. Ltd (REC) and PTC India Financial Services Ltd. The stocks gained 6-8% over the last four days.
PFC PFS PWQFY 532955 RECLTD 532810 533344
New Delhi: The Union government plans to provide ₹1,000 crore as subsidy for building a nationwide charging infrastructure for electric vehicles as it seeks to expedite the roll-out of India’s ambitious EV programme, said two people aware of the development on condition of anonymity.
PFC PWQFY 532955 RECLTD 532810 NTPZY
Shares of Lupin down 2 percent, while JSW Steel touched 52-week high of Rs 379.50, rising more than 3 percent after National Stock Exchange (NSE) announced fresh Nifty rejig effective from September 28.
PWQFY KESORAMIND 500228 BHUSANSTL 533096 532418 532955 MARKSANS 533155 532810 JUBLFOOD ABAN CMQMY 532461 ENGINERSIN JBLWY 532480 CUMMINSIND 500055 502937 524404 ALNSE ALBK JSWSTEEL 532401 VIJAYABANK BRK.A PFC 532178 500480 PNJZY PNB 534809 ADANIPOWER PCJEWELLER RECLTD 523204 KRIDF ANDHRABANK
Shares of Jubilant Foodworks, the operator of Domino's Pizza in India, fell before rising one-third of a percent as traders cheered inclusion of the stock in Nifty Midcap index.
PWQFY ALNSE 533096 533155 532955 532810 JUBLFOOD BRK.A PFC 532178 500480 CMQMY PNJZY 532461 ENGINERSIN JBLWY CUMMINSIND 534809 PNB ADANIPOWER PCJEWELLER RECLTD
State run Rural Electrification Corporation today said it has inked a loan agreement with German bank KfW for EUR 200 million facility that would be used to finance clean energy projects in India.
The Reserve Bank has backed the idea of state-owned Rural Electrification Corporation's proposal to form an asset reconstruction company (ARC) dedicated to take over stressed assets in the power sector. Sources said the RBI in its representations to a panel headed by Financial Services Secretary Rajiv Kumar had said that it is open to proposal of REC setting up an ARC.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...